東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Effects of lifestyle intervention al...

Harden, Kelly A.

FindBook

Google Book

Amazon

博客來

Effects of lifestyle intervention alone or with pharmacotherapy on weight management and metabolic syndrome markers in obese adolescents.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Effects of lifestyle intervention alone or with pharmacotherapy on weight management and metabolic syndrome markers in obese adolescents./
作者:	Harden, Kelly A.
面頁冊數:	98 p.
附註:	Adviser: Patricia A. Cowan.
Contained By:	Dissertation Abstracts International66-09B.
標題:	Health Sciences, Health Care Management. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3190686
ISBN:	9780542341991

Effects of lifestyle intervention alone or with pharmacotherapy on weight management and metabolic syndrome markers in obese adolescents.
Harden, Kelly A.

Effects of lifestyle intervention alone or with pharmacotherapy on weight management and metabolic syndrome markers in obese adolescents. - 98 p.

Adviser: Patricia A. Cowan.

Thesis (D.N.Sc.)--The University of Tennessee Health Science Center, 2005.

Adolescent obesity has become a significant health problem in the United States, nearly tripling in the last thirty years. Aggressive treatment of adolescent obesity is important because the symptoms and co-morbidities are associated with the metabolic syndrome. The purposes of this study are threefold: to determine what components of the metabolic syndrome are present in obese adolescents, to determine what differences exist in the effects of lifestyle intervention verses lifestyle intervention plus pharmacotherapy on weight management and select markers of the metabolic syndrome in obese adolescents, and to determine which factors predict weight loss in obese adolescents treated with lifestyle changes. A retrospective chart review of 68 obese adolescents treated for obesity at the LeBonheur Youth Lifestyle Clinic from January 1, 2000 through June 30, 2005 was performed. The study was a secondary data analysis utilizing existing data from the clinic. Adolescents ages 11 though 18 were included. Lifestyle interventions included diet, exercise, and counseling. Weight loss medications utilized included metformin and phentermine. Outcomes evaluated included Body Mass Index (BMI), Relative Body Mass Index (RBMI), weight, waist and hip circumference, blood pressure, serum lipid levels, fasting plasma glucose, two hour oral glucose tolerance tests, and insulin levels. Changes in mean values between groups were evaluated using the SAS statistical analysis program (version 9.1) Logistic regression was utilized to determine which factors might predict weight loss. The metformin group tended to be heavier, older, and had more components of metabolic syndrome than the nonmetformin group. All components of the metabolic syndrome were present in both groups but metabolic syndrome was more prevalent in the metformin group. Both groups had a downward trend in RBMI, a surrogate marker for weight loss, but the only the metformin group had a significant loss in RBMI points from baseline to end. The only predictors of weight loss were higher RBMI and the absence of Type 2 Diabetes Mellitus (T2DM). While the use of lifestyle changes and lifestyle changes plus pharmacotherapy both produce some degree of weight loss, subjects on metformin in this study lost significantly more RBMI than those on lifestyle changes alone.

ISBN: 9780542341991Subjects--Topical Terms:

1017922
Health Sciences, Health Care Management.

Effects of lifestyle intervention alone or with pharmacotherapy on weight management and metabolic syndrome markers in obese adolescents.
LDR:03335nam 2200289 a 45 001 972925
005 20110928
008 110928s2005 eng d
020 $a 9780542341991
035 $a (UnM)AAI3190686
035 $a AAI3190686
040 $a UnM $c UnM
100 1 $a Harden, Kelly A. $3 1296888
245 1 0 $a Effects of lifestyle intervention alone or with pharmacotherapy on weight management and metabolic syndrome markers in obese adolescents.
300 $a 98 p.
500 $a Adviser: Patricia A. Cowan.
500 $a Source: Dissertation Abstracts International, Volume: 66-09, Section: B, page: 4718.
502 $a Thesis (D.N.Sc.)--The University of Tennessee Health Science Center, 2005.
520 $a Adolescent obesity has become a significant health problem in the United States, nearly tripling in the last thirty years. Aggressive treatment of adolescent obesity is important because the symptoms and co-morbidities are associated with the metabolic syndrome. The purposes of this study are threefold: to determine what components of the metabolic syndrome are present in obese adolescents, to determine what differences exist in the effects of lifestyle intervention verses lifestyle intervention plus pharmacotherapy on weight management and select markers of the metabolic syndrome in obese adolescents, and to determine which factors predict weight loss in obese adolescents treated with lifestyle changes. A retrospective chart review of 68 obese adolescents treated for obesity at the LeBonheur Youth Lifestyle Clinic from January 1, 2000 through June 30, 2005 was performed. The study was a secondary data analysis utilizing existing data from the clinic. Adolescents ages 11 though 18 were included. Lifestyle interventions included diet, exercise, and counseling. Weight loss medications utilized included metformin and phentermine. Outcomes evaluated included Body Mass Index (BMI), Relative Body Mass Index (RBMI), weight, waist and hip circumference, blood pressure, serum lipid levels, fasting plasma glucose, two hour oral glucose tolerance tests, and insulin levels. Changes in mean values between groups were evaluated using the SAS statistical analysis program (version 9.1) Logistic regression was utilized to determine which factors might predict weight loss. The metformin group tended to be heavier, older, and had more components of metabolic syndrome than the nonmetformin group. All components of the metabolic syndrome were present in both groups but metabolic syndrome was more prevalent in the metformin group. Both groups had a downward trend in RBMI, a surrogate marker for weight loss, but the only the metformin group had a significant loss in RBMI points from baseline to end. The only predictors of weight loss were higher RBMI and the absence of Type 2 Diabetes Mellitus (T2DM). While the use of lifestyle changes and lifestyle changes plus pharmacotherapy both produce some degree of weight loss, subjects on metformin in this study lost significantly more RBMI than those on lifestyle changes alone.
590 $a School code: 0783.
650 4 $a Health Sciences, Health Care Management. $3 1017922
650 4 $a Health Sciences, Medicine and Surgery. $3 1017756
650 4 $a Health Sciences, Nutrition. $3 1017801
690 $a 0564
690 $a 0570
690 $a 0769
710 2 0 $a The University of Tennessee Health Science Center. $3 1262886
773 0 $t Dissertation Abstracts International $g 66-09B.
790 $a 0783
790 1 0 $a Cowan, Patricia A., $e advisor
791 $a D.N.Sc.
792 $a 2005
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3190686